George F Murphy Selected Research

George F Murphy Research Topics

Disease

55	Neoplasms (Cancer) 01/2024 - 12/2002
42	Melanoma (Melanoma, Malignant) 11/2023 - 03/2004
26	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2016 - 09/2002
12	Wounds and Injuries (Trauma) 01/2023 - 07/2010
7	Inflammation (Inflammations) 07/2021 - 09/2009
7	Disease Progression 01/2018 - 06/2004
6	Leukemia 08/2013 - 03/2003
5	Nevus (Nevi) 03/2017 - 04/2011
5	Carcinogenesis 11/2015 - 02/2010
4	Cicatrix (Scar) 10/2022 - 07/2013
4	Infections 01/2022 - 05/2012
3	Hypoxia (Hypoxemia) 01/2023 - 02/2011
3	Lymphoma (Lymphomas) 02/2017 - 07/2011
3	Neoplasm Metastasis (Metastasis) 01/2017 - 03/2004
2	Fibrosis (Cirrhosis) 10/2022 - 01/2020
2	Sclerosis 01/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 08/2011
2	Hypersensitivity (Allergy) 11/2016 - 06/2003
2	Cellulitis 08/2016 - 01/2016
2	Skin Neoplasms (Skin Cancer) 04/2016 - 11/2009
2	Fever (Fevers) 01/2016 - 02/2015
2	Dysplastic Nevus Syndrome (Dysplastic Nevus) 07/2015 - 07/2014
2	Necrosis 10/2014 - 03/2014
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2009 - 09/2008
2	Crohn Disease (Crohn's Disease) 09/2009 - 05/2003
1	Lymphadenopathy 02/2024
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2023
1	Bites and Stings (Sting) 01/2023
1	Tics (Tic) 01/2023

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2007
10	Messenger RNA (mRNA)IBA 01/2022 - 11/2003
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2010
10	5-hydroxymethylcytosineIBA 01/2020 - 09/2012
8	CytokinesIBA 01/2022 - 09/2003
6	Adenosine Triphosphate (ATP)IBA 01/2018 - 11/2010
6	AntigensIBA 01/2018 - 09/2009
6	Minor Histocompatibility AntigensIBA 03/2007 - 12/2003
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2014
5	Small Interfering RNA (siRNA)IBA 01/2020 - 08/2008
5	CollagenIBA 01/2019 - 06/2011
5	Transforming Growth Factor beta (TGF-beta)IBA 01/2017 - 08/2008
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2011
4	EnzymesIBA 01/2019 - 09/2012
4	NestinIBA 01/2016 - 04/2011
4	LigandsIBA 09/2015 - 02/2012
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2014 - 02/2011
3	Polysaccharides (Glycans)IBA 01/2023 - 07/2015
3	Imiquimod (Aldara)FDA LinkGeneric 01/2020 - 09/2008
3	Immune Checkpoint InhibitorsIBA 10/2018 - 03/2013
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2017 - 08/2006
3	Monoclonal AntibodiesIBA 01/2017 - 09/2008
3	Keratin-15 (Keratin 15)IBA 02/2016 - 09/2003
3	Histones (Histone)IBA 11/2015 - 08/2014
3	IpilimumabIBA 02/2015 - 05/2012
3	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 10/2014 - 02/2011
3	Laminin (Merosin)IBA 10/2014 - 02/2011
3	MitogensIBA 01/2014 - 01/2010
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2003 - 12/2002
2	InterferonsIBA 11/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2021
2	Adapalene (Differin)FDA LinkGeneric 01/2023 - 10/2014
2	DioxygenasesIBA 01/2020 - 01/2016
2	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2019 - 12/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 08/2011
2	Dacarbazine (DIC)FDA LinkGeneric 01/2017 - 04/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2016 - 01/2016
2	Carboplatin (JM8)FDA LinkGeneric 04/2016 - 10/2014
2	Etoposide (VP 16)FDA LinkGeneric 04/2016 - 10/2014
2	AntibodiesIBA 09/2015 - 03/2003
2	Galectin 1 (LGALS1)IBA 07/2015 - 02/2012
2	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 07/2015 - 02/2012
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2015 - 12/2011
2	cadherin 5IBA 10/2014 - 02/2011
2	TNF-Related Apoptosis-Inducing LigandIBA 06/2013 - 12/2002
2	OvalbuminIBA 10/2012 - 09/2009
2	Interleukin-10 (Interleukin 10)IBA 02/2012 - 11/2009
2	Contrast MediaIBA 04/2011 - 03/2004
1	PlasticsIBA 11/2023
1	Galectins (Galectin)IBA 01/2023
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	poly-N-acetyllactosamineIBA 01/2023
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2023
1	N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase)IBA 01/2023
1	N-acetylglucosaminyltransferase IGnTIBA 01/2023
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2022

Therapy/Procedure

28	Therapeutics 01/2022 - 05/2003
9	Hematopoietic Stem Cell Transplantation 02/2017 - 06/2004
7	Bone Marrow Transplantation (Transplantation, Bone Marrow) 08/2013 - 03/2003
4	Transplantation 02/2024 - 02/2004
4	Heterologous Transplantation (Xenotransplantation) 01/2018 - 01/2008
4	Cell Transplantation 10/2004 - 12/2002
3	Immunotherapy 10/2023 - 02/2012
3	Negative-Pressure Wound Therapy 10/2022 - 02/2011
3	Drug Therapy (Chemotherapy) 01/2018 - 04/2016
2	Vascularized Composite Allotransplantation 02/2024 - 01/2023
2	Facial Transplantation 02/2024 - 10/2018
2	Transjugular Intrahepatic Portasystemic Shunt 06/2012 - 01/2007
1	Ligation 01/2024
1	Surgical Amputation (Amputations) 01/2022